Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Research Information Network (RIN) is a clinical research organization (CRO) and site management organization (SMO) that facilitates the execution of Phase I through Phase IV clinical trials. Headquartered in Encino, California, the company provides a comprehensive suite of services to pharmaceutical and biotechnology sponsors, including site selection, patient recruitment, and clinical study management. RIN specializes in therapeutic areas such as neurology, psychiatry, and internal medicine, operating a network of high-performing clinical research sites. The organization is dedicated to maintaining rigorous regulatory standards and delivering high-quality data to support the global drug development pipeline. By leveraging a dedicated network of clinical sites and experienced investigators, the company helps accelerate the development of new therapies. RIN is frequently chosen as a partner for complex trials involving central nervous system (CNS) disorders.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Research Information Network.